These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 8467468)
21. Abnormalities of chromosome 22 in meningiomas and confirmation of the origin of a dicentric 22 by in situ hybridization. Tonk V; Osella P; Delasmorenas A; Wyandt HE; Milunsky A Cancer Genet Cytogenet; 1992 Nov; 64(1):65-8. PubMed ID: 1458452 [TBL] [Abstract][Full Text] [Related]
22. Loss of heterozygosity for distal markers on 22q in human gliomas. Rey JA; Bello MJ; Jimenez-Lara AM; Vaquero J; Kusak ME; de Campos JM; Sarasa JL; Pestaña A Int J Cancer; 1992 Jul; 51(5):703-6. PubMed ID: 1351884 [TBL] [Abstract][Full Text] [Related]
23. Interphase cytogenetics: a new tool for the study of genetic changes in brain tumors. Arnoldus EP; Wolters LB; Voormolen JH; van Duinen SG; Raap AK; van der Ploeg M; Peters AC J Neurosurg; 1992 Jun; 76(6):997-1003. PubMed ID: 1588436 [TBL] [Abstract][Full Text] [Related]
24. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179 [TBL] [Abstract][Full Text] [Related]
25. Incidence of numerical chromosome aberrations in meningioma tumors as revealed by fluorescence in situ hybridization using 10 chromosome-specific probes. Sayagués JM; Tabernero MD; Maillo A; Díaz P; Rasillo A; Bortoluci A; Gomez-Moreta J; Santos-Briz A; Morales F; Orfao A Cytometry; 2002 Jun; 50(3):153-9. PubMed ID: 12116338 [TBL] [Abstract][Full Text] [Related]
26. Cytogenetic analysis of aggressive meningiomas: possible diagnostic and prognostic implications. Perry A; Jenkins RB; Dahl RJ; Moertel CA; Scheithauer BW Cancer; 1996 Jun; 77(12):2567-73. PubMed ID: 8640707 [TBL] [Abstract][Full Text] [Related]
27. Molecular genetic approach to human meningioma: loss of genes on chromosome 22. Seizinger BR; de la Monte S; Atkins L; Gusella JF; Martuza RL Proc Natl Acad Sci U S A; 1987 Aug; 84(15):5419-23. PubMed ID: 3037550 [TBL] [Abstract][Full Text] [Related]
28. Loss of chromosomes 22 and 14 in the malignant progression of meningiomas. A comparative study of fluorescence in situ hybridization (FISH) and standard cytogenetic analysis. Schneider BF; Shashi V; von Kap-herr C; Golden WL Cancer Genet Cytogenet; 1995 Dec; 85(2):101-4. PubMed ID: 8548731 [TBL] [Abstract][Full Text] [Related]
29. Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression. Rempel SA; Schwechheimer K; Davis RL; Cavenee WK; Rosenblum ML Cancer Res; 1993 May; 53(10 Suppl):2386-92. PubMed ID: 8485725 [TBL] [Abstract][Full Text] [Related]
30. Assessment of chromosome 22 anomalies in neurinomas by combined karyotype and RFLP analyses. Couturier J; Delattre O; Kujas M; Philippon J; Peter M; Rouleau G; Aurias A; Thomas G Cancer Genet Cytogenet; 1990 Mar; 45(1):55-62. PubMed ID: 1967977 [TBL] [Abstract][Full Text] [Related]
31. Cytogenetic analysis of 39 pediatric central nervous system tumors. Karnes PS; Tran TN; Cui MY; Raffel C; Gilles FH; Barranger JA; Ying KL Cancer Genet Cytogenet; 1992 Mar; 59(1):12-9. PubMed ID: 1313329 [TBL] [Abstract][Full Text] [Related]
32. Karyotypes in 90 human gliomas. Thiel G; Losanowa T; Kintzel D; Nisch G; Martin H; Vorpahl K; Witkowski R Cancer Genet Cytogenet; 1992 Feb; 58(2):109-20. PubMed ID: 1551072 [TBL] [Abstract][Full Text] [Related]
33. Deletion mapping of the long arm of chromosome 22 in human meningiomas. Akagi K; Kurahashi H; Arita N; Hayakawa T; Monden M; Mori T; Takai S; Nishisho I Int J Cancer; 1995 Jan; 60(2):178-82. PubMed ID: 7829212 [TBL] [Abstract][Full Text] [Related]
34. Comprehensive DNA copy number profiling of meningioma using a chromosome 1 tiling path microarray identifies novel candidate tumor suppressor loci. Buckley PG; Jarbo C; Menzel U; Mathiesen T; Scott C; Gregory SG; Langford CF; Dumanski JP Cancer Res; 2005 Apr; 65(7):2653-61. PubMed ID: 15805262 [TBL] [Abstract][Full Text] [Related]
35. Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas. Arslantas A; Artan S; Oner U; Durmaz R; Müslümanoğlu H; Atasoy MA; Başaran N; Tel E Acta Neurol Belg; 2002 Jun; 102(2):53-62. PubMed ID: 12161900 [TBL] [Abstract][Full Text] [Related]
36. Human KRAS oncogene expression in meningioma. Carstens C; Messe E; Zang KD; Blin N Cancer Lett; 1988 Dec; 43(1-2):37-41. PubMed ID: 2462463 [TBL] [Abstract][Full Text] [Related]
37. Telomeric fusion as a mechanism for the loss of 1p in meningioma. Sawyer JR; Husain M; Lukacs JL; Stangeby C; Binz RL; Al-Mefty O Cancer Genet Cytogenet; 2003 Aug; 145(1):38-48. PubMed ID: 12885461 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of relationship between chromosome 22 and p53 gene alterations and the subtype of meningiomas by the interphase-FISH technique. Yakut T; Bekar A; Doygun M; Acar H; Egeli U; Ogul E Teratog Carcinog Mutagen; 2002; 22(3):217-25. PubMed ID: 11948632 [TBL] [Abstract][Full Text] [Related]
39. Ascertainment of chromosome 7 gains in malignant gliomas by cytogenetic and RFLP analyses. Bello MJ; de Campos JM; Kusak ME; Vaquero J; Sarasa JL; Petaña A; Rey JA Cancer Genet Cytogenet; 1994 Jan; 72(1):55-8. PubMed ID: 7906611 [TBL] [Abstract][Full Text] [Related]
40. Recessive cancer genes in meningiomas? An analysis of 31 cases. Casalone R; Granata P; Simi P; Tarantino E; Butti G; Buonaguidi R; Faggionato F; Knerich R; Solero L Cancer Genet Cytogenet; 1987 Jul; 27(1):145-59. PubMed ID: 3472644 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]